We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
| Abbreviation | Name |
|---|---|
| AAN | Australian Approved Name |
| AC | Active constituent |
| ACCC | Australian Competition and Consumer Commission |
| ACCM | Advisory Committee on Complementary Medicines (formerly Complementary Medicine Evaluation Committee [CMEC]) |
| ACNM | Advisory Committee on Non-prescription Medicines (formerly Medicines Evaluation Committee [MEC]) |
| ACPM | Advisory Committee on Prescription Medicines (formerly Australian Drug Evaluation Committee [ADEC]) |
| ACSOM | Advisory Committee on the Safety of Medicines (formerly Adverse Drug Reactions Advisory Committee [ADRAC]) |
| ADEC | Australian Drug Evaluation Committee (now Advisory Committee on Prescription Medicines [ACPM]) |
| ADI | Acceptable daily intake |
| ADRAC | Adverse Drug Reactions Advisory Committee (now Advisory Committee on the Safety of Medicines [ACSOM]) |
| AHMAC | Australian Health Ministers' Advisory Council |
| APVMA | Australian Pesticides and Veterinary Medicines Authority |
| AQIS | Australian Quarantine and Inspection Service |
| ARfD | Acute reference dose |
| ASCC | Australian Safety and Compensation Council |
| ASMI | Australian Self-Medication Industry |
| ARTG | Australian Register of Therapeutic Goods |
| CAS | Chemical Abstract Service |
| CHC | Complementary Healthcare Council of Australia |
| CMEC | Complementary Medicine Evaluation Committee (now Advisory Committee on Complementary Medicines [ACCM]) |
| CMI | Consumer Medicine Information |
| COAG | Councils of Australian Governments |
| CRC | Child-resistant closure |
| CTFAA | Cosmetic, Toiletry & Fragrance Association of Australia |
| CWP | Codeine Working Party |
| DAP | Drafting Advisory Panel |
| ECRP | Existing Chemicals Review Program |
| EPA | Environmental Protection Authority |
| ERMA | Environmental Risk Management Authority (New Zealand) |
| EU | European Union |
| FAISD | First Aid Instructions and Safety Directions |
| FDA | Food and Drug Administration (United States) |
| FOI | Freedom of Information Act 1982 |
| FSANZ | Food Standards Australia New Zealand |
| GHS | Globally Harmonised System for Classification and Labelling of Chemicals |
| GIT | Gastro-intestinal tract |
| GP | General practitioner |
| HCN | Health Communication Network |
| IMAP | Inventory Multi-tiered Assessment Prioritisation |
| INN | International Non-proprietary Name |
| ISO | International Standards Organization |
| IUPAC | International Union of Pure and Applied Chemistry |
| LC50 | The concentration of a substance that produces death in 50 per cent of a population of experimental organisms. Usually expressed as mg per litre (mg/L) as a concentration in air. |
| LD50 | The concentration of a substance that produces death in 50 per cent of a population of experimental organisms. Usually expressed as milligrams per kilogram (mg/kg) of body weight. |
| LOAEL | Lowest observed adverse effect level |
| LOEL | Lowest observed effect level |
| MCC | Medicines Classification Committee (New Zealand) |
| MEC | Medicines Evaluation Committee (now Advisory Committee on Non-prescription Medicines [ACNM]) |
| MOH | Ministry of Health (New Zealand) |
| NCCTG | National Coordinating Committee on Therapeutic Goods |
| NDPSC | National Drugs and Poisons Schedule Committee |
| NHMRC | National Health and Medical Research Council |
| NICNAS | National Industrial Chemicals Notification & Assessment Scheme |
| NOAEL | No observed adverse effect level |
| NOEL | No observable effect level |
| NOHSC | National Occupational Health & Safety Commission |
| OCM | Office of Complementary Medicines |
| OCS | Office of Chemical Safety (formerly Office of Chemical Safety and Environmental Health [OCSEH]) |
| OCSEH | Office of Chemical Safety and Environmental Health (now Office of Chemical Safety [OCS]) |
| ODA | Office of Devices Authorisation |
| OMA | Office of Medicines Authorisation (formerly Office of Prescription and Non-prescription Medicines) |
| OOS | Out of session |
| OTC | Over-the-counter |
| PACIA | Plastics and Chemicals Industries Association |
| PAR | Prescription animal remedy |
| PBAC | Pharmaceutical Benefits Advisory Committee |
| PEC | Priority existing chemical |
| PGA | Pharmaceutical Guild of Australia |
| PHARM | Pharmaceutical Health and Rational Use of Medicines |
| PI | Product Information |
| PIC | Poisons Information Centre |
| PSA | Pharmaceutical Society of Australia |
| QCPP | Quality Care Pharmacy Program |
| QUM | Quality Use of Medicines |
| RFI | Restricted flow insert |
| SCCNFP | Scientific Committee on Cosmetic and Non-Food Products |
| SCCP | Scientific Committee on Consumer Products |
| SPF | Scheduling Policy Framework |
| STANZHA | States and Territories and New Zealand Health Authorities |
| SUSDP | Standard for the Uniform Scheduling of Drugs and Poisons |
| SUSMP | Standard for the Uniform Scheduling of Medicines and Poisons |
| SVT | First aid for the solvent prevails |
| TCM | Traditional Chinese medicine |
| TGA | Therapeutic Goods Administration |
| TGC | Therapeutic Goods Committee |
| TGO | Therapeutic Goods Order |
| TTHWP | Trans-Tasman Harmonisation Working Party |
| TTMRA | Trans-Tasman Mutual Recognition Agreement |
| WHO | World Health Organization |
| WP | Working party |
| WS | Warning statement |